Retinal cells suppress intraocular inflammation (uveitis) through production of interleukin-27 and interleukin-10

Immunology

Volumn 132, Issue 4, 2011, Pages 492-502

  Lee, Yun Sang ^a   Amadi Obi, Ahjoku ^a   Yu, Cheng Rong ^a   Egwuagu, Charles E ^a  

^a NATIONAL EYE INSTITUTE   (United States)

Author keywords

Cytokine; Interleukin 10; Interleukin 27; Intraocular inflammatory diseases; Microglia; Retina; Signal transducer and activator of transcription 1

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 27; STAT1 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; MICROGLIA; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PHOTORECEPTOR; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; RETINA NERVE CELL; UPREGULATION; UVEITIS;

AGED; ANIMALS; BLOTTING, WESTERN; CELL LINE; CELLS, CULTURED; CENTRAL NERVOUS SYSTEM; FEMALE; HUMANS; INTERLEUKIN-10; INTERLEUKIN-17; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROGLIA; MICROSCOPY, CONFOCAL; RECEPTORS, INTERLEUKIN; RETINA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STAT1 TRANSCRIPTION FACTOR; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; T-LYMPHOCYTES, REGULATORY; UVEITIS;

EID: 79952527975     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2010.03379.x     Document Type: Article

References (37)

1. Nussenblatt RB. Bench to bedside: new approaches to the immunotherapy of uveitic disease. Int Rev Immunol 2002; 21:273-89.
2. Nussenblatt RB. Proctor lecture. Experimental autoimmune uveitis: mechanisms of disease and clinical therapeutic indications. Invest Ophthalmol Vis Sci 1991; 32:3131-41.
3. Amadi-Obi A, Yu CR, Liu X et al. T(H)17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1. Nat Med 2007; 13:711-8.
4. Nussenblatt RB. The natural history of uveitis. Int Ophthalmol 1990; 14:303-8.
5. Jabs DA, Rosenbaum JT, Foster CS et al. Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. Am J Ophthalmol 2000; 130:492-513.
6. + T cells. Immunity 2002; 16:779-90.
7. Pflanz S, Hibbert L, Mattson J et al. WSX-1 and glycoprotein 130 constitute a signal-transducing receptor for IL-27. J Immunol 2004; 172:2225-31.
8. Hunter CA. New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions. Nat Rev 2005; 5:521-31.
9. Batten M, Li J, Yi S et al. Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells. Nat Immunol 2006; 7:929-36.
10. Fitzgerald DC, Zhang GX, El-Behi M et al. Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T cells. Nat Immunol 2007; 8:1372-9.
11. Takase H, Yu CR, Liu X, Fujimoto C, Gery I, Egwuagu CE. Induction of suppressors of cytokine signaling (SOCS) in the retina during experimental autoimmune uveitis (EAU): potential neuroprotective role of SOCS proteins. J Neuroimmunol 2005; 168:118-27.
12. Jackson SH, Yu CR, Mahdi RM, Ebong S, Egwuagu CE. Dendritic cell maturation requires STAT1 and is under feedback regulation by suppressors of cytokine signaling. J Immunol 2004; 172:2307-15.
13. Egwuagu CE, Yu CR, Zhang M, Mahdi RM, Kim SJ, Gery I. Suppressors of cytokine signaling proteins are differentially expressed in Th1 and Th2 cells: implications for Th cell lineage commitment and maintenance. J Immunol 2002; 168:3181-7.
14. + T cells prevents development of experimental autoimmune diseases. J Immunol 2008; 180:6070-6.
15. Hume DA, Perry VH, Gordon S. Immunohistochemical localization of a macrophage-specific antigen in developing mouse retina: phagocytosis of dying neurons and differentiation of microglial cells to form a regular array in the plexiform layers. J Cell Biol 1983; 97:253-7.
16. Sonobe Y, Yawata I, Kawanokuchi J, Takeuchi H, Mizuno T, Suzumura A. Production of IL-27 and other IL-12 family cytokines by microglia and their subpopulations. Brain Res 2005; 1040:202-7.
17. Li J, Gran B, Zhang GX, Rostami A, Kamoun M. IL-27 subunits and its receptor (WSX-1) mRNAs are markedly up-regulated in inflammatory cells in the CNS during experimental autoimmune encephalomyelitis. J Neurol Sci 2005; 232:3-9.
18. Crabe S, Guay-Giroux A, Tormo AJ et al. The IL-27 p28 subunit binds cytokine-like factor 1 to form a cytokine regulating NK and T cell activities requiring IL-6R for signaling. J Immunol 2009; 183:7692-702.
19. Awasthi A, Carrier Y, Peron JP et al. A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells. Nat Immunol 2007; 8:1380-9.
20. Stumhofer JS, Silver JS, Laurence A et al. Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10. Nat Immunol 2007; 8:1363-71.
21. Bettelli E, Sullivan B, Szabo SJ, Sobel RA, Glimcher LH, Kuchroo VK. Loss of T-bet, but not STAT1, prevents the development of experimental autoimmune encephalomyelitis. J Exp Med 2004; 200:79-87.
22. + regulatory T cells in the absence of STAT1: increased susceptibility to autoimmune disease. J Exp Med 2004; 199:25-34.
23. Balasubramaniam B, Carter DA, Mayer EJ, Dick AD. Microglia derived IL-6 suppresses neurosphere generation from adult human retinal cell suspensions. Exp Eye Res 2009; 89:757-66.
24. Diveu C, McGeachy MJ, Boniface K et al. IL-27 blocks RORc expression to inhibit lineage commitment of Th17 cells. J Immunol 2009; 182:5748-56.
25. Owaki T, Asakawa M, Kamiya S, Takeda K, Fukai F, Mizuguchi J, Yoshimoto T. IL-27 suppresses CD28-mediated IL-2 production through suppressor of cytokine signaling 3. J Immunol 2006; 176:2773-80.
26. Caspi RR, Chan CC, Grubbs BG et al. Endogenous systemic IFN-γ has a protective role against ocular autoimmunity in mice. J Immunol 1994; 152:890-9.
27. Tarrant TK, Silver PB, Wahlsten JL, Rizzo LV, Chan CC, Wiggert B, Caspi RR. Interleukin 12 protects from a T helper type 1-mediated autoimmune disease, experimental autoimmune uveitis, through a mechanism involving interferon γ, nitric oxide, and apoptosis. J Exp Med 1999; 189:219-30.
28. Villarino AV, Stumhofer JS, Saris CJ, Kastelein RA, de Sauvage FJ, Hunter CA. IL-27 limits IL-2 production during Th1 differentiation. J Immunol 2006; 176:237-47.
29. Hilton DJ. Negative regulators of cytokine signal transduction. Cell Mol Life Sci 1999; 55:1568-77.
30. Hilton DJ, Richardson RT, Alexander WS et al. Twenty proteins containing aC-terminal SOCS box form five structural classes. Proc Natl Acad Sci USA 1998; 95:114-9.
31. Berlato C, Cassatella MA, Kinjyo I, Gatto L, Yoshimura A, Bazzoni F. Involvement of suppressor of cytokine signaling-3 as a mediator of the inhibitory effects of IL-10 on lipopolysaccharide-induced macrophage activation. J Immunol 2002; 168:6404-11.
32. Gasperini S, Crepaldi L, Calzetti F, Gatto L, Berlato C, Bazzoni F, Yoshimura A, Cassatella MA. Interleukin-10 and cAMP-elevating agents cooperate to induce suppressor of cytokine signaling-3 via a protein kinase A-independent signal. Eur Cytokine Netw 2002; 13:47-53.
33. Matsumoto A, Seki Y, Watanabe R et al. A role of suppressor of cytokine signaling 3 (SOCS3/CIS3/SSI3) in CD28-mediated interleukin 2 production. J Exp Med 2003; 197:425-36.
34. Liu X, Mameza MG, Lee YS, Eseonu CI, Yu CR, Kang Derwent JJ, Egwuagu CE. Suppressors of cytokine-signaling proteins induce insulin resistance in the retina and promote survival of retinal cells. Diabetes 2008; 57:1651-8.
35. Egwuagu CE, Yu CH, Mahdi RM, Mameza M, Eseonu C, Takase H, Ebong S. Cytokine-induced retinal degeneration: role of suppressors of cytokine signaling (SOCS) proteins in protection of the neuroretina. Adv Exp Med Biol 2006; 572:275-81.
36. Nussenblatt RB, Palestine AG, Chan CC, Roberge F. Standardization of vitreal inflammatory activity in intermediate and posterior uveitis. Ophthalmology 1985; 92:467-71.
37. Nussenblatt RB, Thompson DJ, Li Z et al. Humanized anti-interleukin-2 (IL-2) receptor alpha therapy: long-term results in uveitis patients and preliminary safety and activity data for establishing parameters for subcutaneous administration. J Autoimmun 2003; 21:283-93.